147 related articles for article (PubMed ID: 3155660)
21. Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia.
Parreira A; Pombo de Oliveira MS; Matutes E; Foroni L; Morilla R; Catovsky D
Br J Haematol; 1988 Jun; 69(2):219-24. PubMed ID: 3164631
[TBL] [Abstract][Full Text] [Related]
22. Phenotype of the terminal transferase-positive cells in human foetal liver and bone-marrow: analysis with monoclonal antibodies.
Bonati A; Delia D; Starcich B; Buscaglia M
Scand J Haematol; 1984 Nov; 33(5):418-24. PubMed ID: 6393319
[TBL] [Abstract][Full Text] [Related]
23. Terminal deoxynucleotidyl transferase in acute myeloid leukaemia.
Jani P; Verbi W; Greaves MF; Bevan D; Bollum F
Leuk Res; 1983; 7(1):17-29. PubMed ID: 6572772
[TBL] [Abstract][Full Text] [Related]
24. Chromatographic forms of terminal deoxynucleotidyl transferase in normal lymphoid cells and in leukemia cells at presentation and relapse.
Bell R; Lillquist A; Abelson H; McCaffrey R
Leuk Res; 1982; 6(6):775-80. PubMed ID: 6984113
[TBL] [Abstract][Full Text] [Related]
25. Induction of terminal deoxynucleotidyl transferase and Lyt antigens with thymosin: identification of multiple subsets of prothymocytes in mouse bone marrow and spleen.
Goldschneider I; Ahmed A; Bollum FJ; Goldstein AL
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2469-73. PubMed ID: 6972536
[TBL] [Abstract][Full Text] [Related]
26. Multiparameter flow cytometric analysis of human fetal bone marrow B cells.
LeBien TW; Wörmann B; Villablanca JG; Law CL; Steinberg LM; Shah VO; Loken MR
Leukemia; 1990 May; 4(5):354-8. PubMed ID: 1697009
[TBL] [Abstract][Full Text] [Related]
27. Immunologic complexity of lymphoblastic lymphoma.
Grogan T; Spier C; Wirt DP; Hicks MJ; Paquin M; Hutter J; Miller T; Rangel C; Richter L; Jones S
Diagn Immunol; 1986; 4(2):81-8. PubMed ID: 3086016
[TBL] [Abstract][Full Text] [Related]
28. Proliferation of normal and malignant human immature lymphoid cells.
Campana D; Janossy G
Blood; 1988 May; 71(5):1201-10. PubMed ID: 3162813
[TBL] [Abstract][Full Text] [Related]
29. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic analysis of acute lymphoblastic leukemia (ALL) cells which are classified as non-T non-B and negative for common ALL antigen.
Kita K; Nasu K; Kamesaki H; Doi S; Tezuka H; Tatsumi E; Fukuhara S; Nishikori M; Uchino H; Shirakawa S
Blood; 1985 Jul; 66(1):47-52. PubMed ID: 3159446
[TBL] [Abstract][Full Text] [Related]
31. Cell surface markers in leukemia: biological and clinical correlations.
Thiel E
Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
[TBL] [Abstract][Full Text] [Related]
32. Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry.
Gore SD; Kastan MB; Goodman SN; Civin CI
J Immunol Methods; 1990 Sep; 132(2):275-86. PubMed ID: 1698878
[TBL] [Abstract][Full Text] [Related]
33. Clonal proliferation unlinked to terminal deoxynucleotidyl transferase synthesis in thymocytes of young mice.
Rothenberg E; Triglia D
J Immunol; 1983 Apr; 130(4):1627-33. PubMed ID: 6601132
[TBL] [Abstract][Full Text] [Related]
34. Defective lymphopoiesis in bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. I. Analysis of development of prothymocytes, early B lineage cells, and terminal deoxynucleotidyl transferase-positive cells.
Greiner DL; Goldschneider I; Komschlies KL; Medlock ES; Bollum FJ; Schultz L
J Exp Med; 1986 Oct; 164(4):1129-44. PubMed ID: 3531380
[TBL] [Abstract][Full Text] [Related]
35. Induction of cALL antigen and terminal deoxynucleotidyltransferase in normal peripheral lymphocytes during PHA stimulation.
Jäger G; Lau B; Dörmer P
Leuk Res; 1982; 6(3):421-3. PubMed ID: 6956784
[TBL] [Abstract][Full Text] [Related]
36. Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens.
Ryan D; Kossover S; Mitchell S; Frantz C; Hennessy L; Cohen H
Blood; 1986 Aug; 68(2):417-25. PubMed ID: 2942198
[TBL] [Abstract][Full Text] [Related]
37. [Immunologic and enzymatic markers of acute infantile lymphoblastic leukemias].
González M; Tamagnini G; San Miguel JF; Lopes DT; Mateos G; Caballero MD; Ribeiro L; López Borrasca A
An Esp Pediatr; 1984 Sep; 21(3):222-8. PubMed ID: 6594963
[TBL] [Abstract][Full Text] [Related]
38. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
39. Method for the simultaneous labelling of terminal deoxynucleotidyl transferase (TdT) and membrane antigens.
Tavares de Castro J; San Miguel JF; Soler J; Catovsky D
J Clin Pathol; 1984 Jun; 37(6):628-32. PubMed ID: 6202720
[TBL] [Abstract][Full Text] [Related]
40. Combined flow cytometric assessment of cell surface antigens and nuclear TdT for the detection of minimal residual disease in acute leukaemia.
Drach J; Gattringer C; Huber H
Br J Haematol; 1991 Jan; 77(1):37-42. PubMed ID: 1998595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
